Search results with tag "Public assessment report decentralised procedure"
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure SVELUX 200MG/25MG MODIFIED-RELEASE CAPSULES, HARD Procedure No: UK/H/5033/001/DC UK Licence No: PL 04416/1362
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure SimAlvia 60 mg/300 mg, soft capsules (alverine citrate and simeticone) Procedure No: UK/H/5633/001/DC
Public Assessment Report Decentralised Procedure …
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Propafenone hydrochloride 150mg and 300mg Film-coated Tablets PL 20620/0034-5; UK/H/1208/01-02/DC 1 Public Assessment Report Decentralised Procedure
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Deferoxamine 500 mg and 2 g Powder for Solution for Injection of Infusion UK/H/3325/001-2/DC 1 Public Assessment Report Decentralised Procedure
Public Assessment Report Decentralised Procedure …
www.mhra.gov.uk111111 Public Assessment Report Decentralised Procedure Heparin Sodium 5,000 IU/ml, solution for injection (Heparin Sodium) UK/H/6565/0001/DC
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure CANDESARTAN CILEXETIL 4 MG TABLETS CANDESARTAN CILEXETIL 8 MG TABLETS CANDESARTAN CILEXETIL 16 MG TABLETS
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure Sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension Sirdupla 25 microgram/250 microgram per metered
Public Assessment Report Decentralised Procedure …
www.mhra.gov.ukPAR Omega-3-acid ethyl ester 1000mg Soft Capsules UK/H/2056/001/DC 1 Public Assessment Report Decentralised Procedure Omega-3-acid …
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure TOPIRAMATE 25MG FILM-COATED TABLETS TOPIRAMATE 50MG FILM-COATED TABLETS TOPIRAMATE 100MG FILM-COATED TABLETS
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Equasym XL 40 mg, 50 mg and 60 mg modified-release capsules, hard UK/H/0819/004-6/DC 1. Public Assessment Report . Decentralised Procedure
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure METFORMIN HYDROCHLORIDE 500MG FILM-COATED TABLETS METFORMIN HYDROCHLORIDE 850MG FILM-COATED TABLETS
Public Assessment Report Decentralised Procedure ...
www.mhra.gov.ukPAR Zoledronic Acid 4mg/5ml concentrate for solution for infusion UK/H/ 5370/001/DC 1. Public Assessment Report . Decentralised Procedure . Zoledronic Acid 4mg/5ml concentrate for solution for infusion
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure MOLITA 200MG/25MG MODIFIED-RELEASE CAPSULES, HARD DIPYRIDAMOLE/ACETYLSALICYLIC ACID 200MG/25MG MODIFIED …
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure BINOSTO 70 MG EFFERVESCENT TABLETS (alendronate sodium) UK/H/3515/001/DC UK licence no: PL 42786/0001
Public Assessment Report Decentralised Procedure ... - …
www.mhra.gov.ukThis is a summary of the Public Assessment Report (PAR) for Rasagiline 1mg Tablets (PL 24668/0302; UK/H/5959/001/DC). It explains how Rasagiline 1mg Tablets was assessed and its authorisation
Public Assessment Report Decentralised Procedure Orlistat ...
www.mhra.gov.ukThis is a summary of the Public Assessment Report (PAR) for Orlistat Mylan 60 mg capsules, hard (PL 04569/1359; UK/H/5278/001/DC). It explains how Orlistat Mylan 60 mg capsules, hard was assessed
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Clobavate 0.05% w/w Ointment UK/H/3212/001/DC 9 Module 5 Scientific discussion during initial procedure I INTRODUCTION Based on the review of the data on quality, safety and efficacy, the member states considered
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Bortezomib Koanaa 3.5 mg powder for solution for injection UK/H/6231/001/DC 3 The usual starting dose of Bortezomib Koanaa is 1.3 mg/m² body surface area twice a week.
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Candesartan Cilexetil 8 mg, 16 mg and 32 mg Tablets UK/H/3930, 4698 & 4699/001-3/DC 2 LAY SUMMARY On 3rd November 2011, the MHRA granted Teva UK Limited Marketing Authorisations (licences) for Candesartan cilexetil 8 mg, 16 mg and 32 mg Tablets.
Public Assessment Report Decentralised Procedure …
www.mhra.gov.ukPAR Ondansetron 2mg/ml Solution for Injection UK/H/1240/01/DC 2 LAY SUMMARY On 23rd July 2009, the UK granted Claris Lifesciences UK Limited a Marketing Authorisation (licences) for the medicine Ondansetron 2mg/ml Solution for Injection.
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Co-Amoxiclav 250mg/125 and 500mg/125mg Film-Coated Tablets UK/H/3244/001-2/DC 6 Renal impairment Dose adjustments are based on the maximum recommended level of amoxicillin.
Similar queries
Public Assessment Report Decentralised Procedure, Soft, Procedure, Hydrochloride, Public Assessment Report Decentralised Procedure Heparin, Acid, Public Assessment Report Decentralised Procedure Omega, TABLETS, Public Assessment Report . Decentralised Procedure, Public Assessment Report Decentralised Procedure METFORMIN, METFORMIN, Public Assessment Report . Decentralised Procedure . Zoledronic, ACETYLSALICYLIC ACID, Capsules, Ointment, 1240, 250mg, Amoxicillin